site map

News Releases

2010
2009
2008
2007
2006
2005
2004

 

 June 1, 2010 Protox to Present Phase 2B BPH Data at the Annual Meeting of the American Urological Association

 

 May 13, 2010 Protox Reports First Quarter 2010 Financial Results

 

 April 29, 2010 Protox Signs $75 Million License Agreement with Kissei for Commercialization of PRX302 in Japan for BPH and Prostate Disease

 

 March 31, 2010 Protox Reports 2009 Financial Results and Achievements

 

 March 16, 2010 Protox Completes Private Placement

 

 February 25, 2010 Protox Revises Terms Of Private Placement

 

 February 24, 2010 Protox To Present At The Third International Symposium On Focal Therapy And Imaging Of Prostate And Kidney Cancer

 

 February 4, 2010 Protox Announces Private Placement

 

 January 11, 2010 Protox Announces Positive Phase 2B BPH Results

2006 Protox Therapeutics Inc. All Rights Reserved. Legal Disclaimer.

What's New

June 2 2010
Protox Announces Positive Six Month Phase 2B BPH Results

June 1, 2010
Protox to Present Phase 2B BPH Data at the Annual Meeting of the American Urological Association

May 13, 2010
Protox Reports First Quarter 2010 Financial Results

April 29, 2010
Protox Signs $75 Million License Agreement with Kissei for Commercialization of PRX302 in Japan for BPH and Prostate Disease

 

Events

January 11, 2010 - 8:45 am ET
Protox Therapeutics Conference Call - Webcast Link

 

Stock Quote

LAST TRADE:$0.39
TRADE TIME:3:53PM EST
CHANGE:$0.00 (0.00%)
PREV CLOSE: $0.39
OPEN:$0.39
BID:$0.385
ASK:$0.39